mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.09 |
mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.05 |
0.09 |
mRNA |
Doxorubicin |
gCSI |
pan-cancer |
AAC |
0.091 |
0.09 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.1 |
mRNA |
GDC-0941 |
GDSC1000 |
pan-cancer |
AAC |
0.056 |
0.1 |
mRNA |
Nilotinib |
CCLE |
pan-cancer |
AAC |
-0.083 |
0.1 |
mRNA |
spautin-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.1 |
mRNA |
HLI 373 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |
mRNA |
Sunitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.086 |
0.1 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.1 |